Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSCAR in Men With Initial Negative Prostate Biopsies
NCT00542243Phase 3Completed
- Sponsor
- University Health Network
- Start
- Feb 2008
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in prostate cancer (PCa) and benign prostatic hyperplasia (BPH) comparing Finasteride with Placebo (2 arms). Primary endpoint: Rate of prostate cancer at repeat TRUS guided biopsy at 6 months. Started Feb 2008; status: completed.
02
Drugs
finasteride
03
Conditions
prostate cancer (PCa)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00542243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542243.